INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 285 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,720,250 | +207.6% | 225,000 | +219.7% | 2.14% | +185.4% |
Q1 2023 | $3,810,590 | -16.4% | 70,371 | -82.4% | 0.75% | +29.9% |
Q4 2018 | $4,556,000 | +5.0% | 400,000 | +100.0% | 0.58% | -14.8% |
Q3 2018 | $4,340,000 | +11.8% | 200,000 | +100.0% | 0.68% | -39.2% |
Q2 2016 | $3,882,000 | – | 100,000 | – | 1.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
RA Capital Management | 314,349 | $12,587,000 | 1.81% |
WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |